Financials

  • Market Capitalization 2.04 B
  • Employee 167
  • Founded 2019
  • CEO N/A
  • Website www.zenasbio.com
  • Headquarter Delaware, United States
  • FIGI BBG01J1MG9D6
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.64
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1975
ADMA
ADMA Biologics Inc - Common Stock
9.34 USD-1.48%-4.69%+8.73%-45.35%2.09 B USD
1994
STOK
Stoke Therapeutics, Inc. - Common Stock
31.62 USD-2.98%-2.07%+10.48%+59.78%2.04 B USD
2006
ZYME
Zymeworks Inc. - Common Stock
28.27 USD-2.55%-1.40%+28.79%+59.36%2.01 B USD
2007
NBTX
Nanobiotix S.A. - ADSs
41.23 USD-8.70%+1.25%+9.74%+397.35%2.00 B USD